Clients
HERON is proud to have attracted and retained a prestigious range of pharmaceutical, biotech, and medical device/diagnostic clients over the past decade, along with government agencies and policy and advocacy groups.
By aligning the scientific and analytic requirements of medical product development with the more strategic and value-based concepts inherent in market access and treatment delivery, HERON’s expertise leads to exciting collaborations that cross internal departments (e.g. HEOR and marketing), market segments, therapeutic areas, and geographies. Our interest is in advancing access to evidence-based health treatments globally and it would be our pleasure to speak with interested parties in that regard.
HERON’s current and former clients include:
- 3M Health Care Ltd
- Actelion Pharmaceuticals UK Ltd
- Actelion Pharmaceuticals International Ltd
- Allergan, Inc.
- Allergan Ltd
- Amgen Inc.
- Aventis Pharma Ltd
- ALTANA Pharma AG
- Astellas
- Astra Zeneca
- Baxter Healthcare Pharmaceutical Ltd
- Biogen Idec Inc.
- Biogen Idec UK Ltd
- Boston Scientific (UK) Ltd
- Boston Scientific International B.V.
- Boerhinger Ingelheim Limited
- Bristol-Myers Squibb Pharmaceuticals Ltd
- ConvaTec UK Ltd
- Elan Corporation, plc.
- Galderma (UK) LTd
- Galderma International
- GE Healthcare
- Genentech Inc.
- GlaxoSmithKline
- F. Hoffmann-La Roche Ltd
- Janssen Pharmaceutica N.V
- Johnson & Johnson Pharma R & D, L.L.C.
- Medeus Pharma Ltd
- Merck Sharp & Dohme Ltd
- Merck & Co, Inc
- Novartis International AG
- Organon Laboratories Ltd
- Laboratoire Organon France
- Pfizer Limited
- Pfizer Inc.
- Procter & Gamble Pharmaceuticals UK Ltd
- Roche Products Ltd
- Roche Diagnostics Ltd
- Sanofi-Aventis UK
- Serono International S.A.
- Schering Oy
- UCB
- Wyeth Pharmaceuticals Ltd
- Wyeth-Lederle Austria/ECE